Dacarbazine (DTIC)-induced human liver damage light and electron-microscopic findings - PubMed (original) (raw)
- PMID: 6884975
Case Reports
Dacarbazine (DTIC)-induced human liver damage light and electron-microscopic findings
H Dancygier et al. Hepatogastroenterology. 1983 Jun.
Abstract
The first electron-microscopic description of DTIC-induced human liver injury is presented. A 61-year-old man developed signs of hepatic failure during the second treatment cycle with DTIC for malignant melanoma. Light-microscopic examination revealed extensive centrilobular liver necrosis. Terminal hepatic venules did not show any signs of vasculitis or thrombosis and there was a lack of inflammatory infiltration. At the ultrastructural level intracytoplasmic, membrane-bound, organelle-free vacuoles were found in the hepatocytes. Liver cells showed bleb formation. Bile canaliculi were dilated and their microvilli flattened. In the pericanalicular exoplasm electron-dense fibrillary material, thought to be of microfilamentous origin, accumulated. The patient received 250 mg methylprednisolone i.v. at the very onset of symptoms and was discharged 12 days after the peak rise of transaminases with normal liver parameters.
Similar articles
- Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma.
Frosch PJ, Czarnetzki BM, Macher E, Grundmann E, Gottschalk I. Frosch PJ, et al. J Cancer Res Clin Oncol. 1979;95(3):281-6. doi: 10.1007/BF00410649. J Cancer Res Clin Oncol. 1979. PMID: 528568 - Acute liver dystrophy with thrombosis of hepatic veins: a fatal complication of dacarbazine treatment.
Féaux de Lacroix W, Runne U, Hauk H, Doepfmer K, Groth W, Wacker D. Féaux de Lacroix W, et al. Cancer Treat Rep. 1983 Sep;67(9):779-84. Cancer Treat Rep. 1983. PMID: 6883354 - Hepatic veno-occlusive disease due to DTIC.
Asbury RF, Rosenthal SN, Descalzi ME, Ratcliffe RL, Arseneau JC. Asbury RF, et al. Cancer. 1980 May 15;45(10):2670-4. doi: 10.1002/1097-0142(19800515)45:10<2670::aid-cncr2820451031>3.0.co;2-l. Cancer. 1980. PMID: 7379000 - Copper and liver injury--experimental studies on the dogs with biliary obstruction and copper loading.
Azumi N. Azumi N. Hokkaido Igaku Zasshi. 1982 May;57(3):331-49. Hokkaido Igaku Zasshi. 1982. PMID: 7129350 - Fatal hepatic toxicity of DTIC: a new case.
Quinio P, Bouche O, Lambolais C, Savry C, Cartier H, Egreteau JP. Quinio P, et al. Intensive Care Med. 1997 Oct;23(10):1099. Intensive Care Med. 1997. PMID: 9407248 No abstract available.
Cited by
- Treatment-related adverse events of immune checkpoint inhibitors in clinical trials: a systematic review and meta-analysis.
Shen X, Yang J, Qian G, Sheng M, Wang Y, Li G, Yan J. Shen X, et al. Front Oncol. 2024 May 17;14:1391724. doi: 10.3389/fonc.2024.1391724. eCollection 2024. Front Oncol. 2024. PMID: 38826783 Free PMC article. - Current status and perspectives in immunotherapy for metastatic melanoma.
Marconcini R, Spagnolo F, Stucci LS, Ribero S, Marra E, Rosa F, Picasso V, Di Guardo L, Cimminiello C, Cavalieri S, Orgiano L, Tanda E, Spano L, Falcone A, Queirolo P; Italian Melanoma Intergroup (IMI). Marconcini R, et al. Oncotarget. 2018 Jan 3;9(15):12452-12470. doi: 10.18632/oncotarget.23746. eCollection 2018 Feb 23. Oncotarget. 2018. PMID: 29552325 Free PMC article. Review. - Phase II study of the immune-checkpoint inhibitor ipilimumab plus dacarbazine in Japanese patients with previously untreated, unresectable or metastatic melanoma.
Yamazaki N, Uhara H, Fukushima S, Uchi H, Shibagaki N, Kiyohara Y, Tsutsumida A, Namikawa K, Okuyama R, Otsuka Y, Tokudome T. Yamazaki N, et al. Cancer Chemother Pharmacol. 2015 Nov;76(5):969-75. doi: 10.1007/s00280-015-2870-0. Epub 2015 Sep 25. Cancer Chemother Pharmacol. 2015. PMID: 26407818 Free PMC article. Clinical Trial. - Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma.
Wolchok JD, Hodi FS, Weber JS, Allison JP, Urba WJ, Robert C, O'Day SJ, Hoos A, Humphrey R, Berman DM, Lonberg N, Korman AJ. Wolchok JD, et al. Ann N Y Acad Sci. 2013 Jul;1291(1):1-13. doi: 10.1111/nyas.12180. Epub 2013 Jun 17. Ann N Y Acad Sci. 2013. PMID: 23772560 Free PMC article. Review. - How recent advances in immunotherapy are changing the standard of care for patients with metastatic melanoma.
Wolchok J. Wolchok J. Ann Oncol. 2012 Sep;23 Suppl 8(Suppl 8):viii15-21. doi: 10.1093/annonc/mds258. Ann Oncol. 2012. PMID: 22918923 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical